vimarsana.com

Page 3 - இந்தியா உலகளாவிய நோய்த்தடுப்பு ப்ரோக்ராம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Message on phone to be ticket to immunity | India News

Message on phone to be ticket to immunity

Message on phone to be ticket to immunity SECTIONS Share Synopsis While the government has automatically registered healthcare and frontline workers on Co-WIN, others in the priority population groups will be able to register themselves with required identification documents for vaccination, once the app is launched. Agencies The software solution was rigorously tested during the vaccination mock drills to ensure operational feasibility of Co-WIN in large-scale use. (This story originally appeared in on Jan 07, 2021)NEW DELHI: With the government set to rollout the Covid vaccination drive next week, many across the country, especially in the healthcare workforce, are waiting to receive a message on their phones intimating them about their inclusion on the beneficiary list and to know the schedule for receiving the vaccine.

With Covid vaccines being sped up, Modi govt builds mechanism to monitor adverse reactions

With Covid vaccines being sped up, Modi govt builds mechanism to monitor adverse reactions India already has an ‘adverse events following immunisation’ or AEFI system for its existing programmes, but Covid vaccination is set to be very different. Abantika Ghosh 15 December, 2020 8:33 pm IST Text Size: A+ New Delhi: As India prepares to launch its largest vaccination programme, likely with a Covid-19 vaccine that has only been given expedited approval because of the current pandemic situation, the Government of India has begun to put in place an elaborate mechanism for monitoring adverse events following immunisation (AEFI). The Covid vaccination programme will be unique also because it will only target adults, and states have been asked to rapidly detect and promptly respond to any AEFIs to ensure public confidence in the new vaccine does not wane.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.